| Characteristics |
Total (n=34) |
| Age, mean ± SD, years |
43.05 ± 9.92 |
| Male gender, No (%) |
18 (52.95%) |
| Transplant from living donor |
16 (47.05%) |
| Mean Conversion day after KT, months |
29.8 ± 15.0 |
| Mean follow up, months |
28.0 ± 4.41 |
| Advagraf dose†, mean ± SD, mg |
2.56 ± 1.24 |
| Advagraf level†, mean ± SD, ng/mL |
3.00 ± 0.51 |
| Sirolimus dose†, mean ± SD, mg |
1.74 ± 0.50 |
| Sirolimus level†, mean ± SD, ng/mL |
6.64 ± 2.01 |
All data are expressed as mean ± SD.
†The dose and level of the drugs were measured at 3 months after conversion. |
